SPARC and tumor growth: Where the seed meets the soil?

Journal of Cellular Biochemistry

Volumn 92, Issue 4, 2004, Pages 679-690

  Framson, Paul E ^a   Sage, E Helene ^a  

^a HOPE HEART INSTITUTE   (United States)

Author keywords

Angiogenesis; Cancer; Collagen; Desmoplasia; Extracellular matrix; Hevin; Inflammation; Matricellular; SPARC; Tumor

Indexed keywords

MEMBRANE PROTEIN; OSTEONECTIN; OSTEOPONTIN; PROTEIN HEVIN; TENASCIN; TENASCIN X; THROMBOSPONDIN 1; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; GLYCOPROTEIN; SCLEROPROTEIN; SPARCL1 PROTEIN, HUMAN;

ARTICLE; CANCER; CELL CULTURE; EXTRACELLULAR SPACE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SEQUENCE HOMOLOGY; STROMA; TUMOR GROWTH; ANIMAL; CELL DIFFERENTIATION; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; NEOPLASMS; OSTEONECTIN;

EID: 10644250277     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20091     Document Type: Article

References (77)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. 2001. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556-7562.
2. Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. 2003. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 163:1801-1815.
3. Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A. 2002. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440: 128-133.
4. Bendik I, Schraml P, Ludwig CU. 1998. Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer. Cancer Res 58: 626-629.
5. Herman DM, Karhadkar SS, Maitra A, Montes de Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. 2003. Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425:846-851.
6. Bornstein P, Sage EH. 2002. Matricellular proteins: Extracellular modulators of cell function. Curr Opin Cell Biol 14:608-616.
7. Bradshaw AD, Sage EH. 2001. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049-1054.
8. Bradshaw AD, Reed MJ, Sage EH. 2002. SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem 50:1-10.
9. Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Sage EH. 2003a. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120:949-955.
10. Bradshaw AD, Graves DC, Motamed K, Sage EH. 2003b. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA 100:6045-6050.
11. Brekken RA, Sage EH. 2001. SPARC, a matricellular protein: At the crossroads of cell-matrix communication. Matrix Biol 19:816-827.
12. Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, Sage EH. 2003. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest 111:487-495.
13. Charrière G, Cousin B, Arnaud E, Andrè M, Bacou F, Pènicaud L, Casteilla L. 2003. Preadipocyte conversion to macrophage. J Biol Chem 278:9850-9855.
14. Chlenski A, Liu S, Crawford SE, Volpert OV, DeVries GH, Evangelista A, Yang Q, Salwen HR, Farrer R, Bray J, Cohn SL. 2002. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res 62:7357-7363.
15. Claeskens A, Ongenae N, Neefs JM, Cheyns P, Kaijen P, Cools M, Kutoh E. 2000. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br J Cancer 82:1123-1130.
16. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-867.
17. Davis GE, Bayless KJ, Mavila A. 2002. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec 268:252-275.
18. Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. 2000. Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Inves 105:915-923.
19. Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, Delespesse G, Sarfati M. 2003. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med 198:1277-1283.
20. Dranoff G. 2004. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4:11-22.
21. Dvorak HF. 2003. Rous-Whipple award lecture. Am J Pathol 162:1747-1757.
22. Fidler IJ. 2003. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
23. Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ, Carbon JG, Sage EH. 2003. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling. J Histochem Cytochem 51: 503-511.
24. Fromigue O, Louis K, Dayem M, Milanini J, Pages G, Tartare-Deckert S, Ponzio G, Hofman P, Barbry P, Auberger P, Mari B. 2003. Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival. Oncogene 22:8487-8497.
25. Girard JP, Springer TA. 1996. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J Biol Chem 271:4511-4517.
26. Gongidi V, Ring C, Moody M, Brekken R, Sage EH, Rakic P, Anton ES. 2004. SPARC-like 1 regulates the terminal phase of radial glia-guided migration in the cerebral cortex. Neuron 41:57-69.
27. Gretz JE, Anderson AO, Shaw S. 1997. Cords, channels, corridors and conduits: Critical architectural elements facilitating cell interactions in the lymph node cortex. Immuonol Rev 156:11-24.
28. Grinnell F. 2003. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13:264-269.
29. Hambrock HO, Nitsche DP, Hansen U, Bruckner P, Paulsson M, Maurer P, Hartmann U. 2003. SC1/hevin. An extracellular calcium-modulated protein that binds collagen I. J Biol Chem 278:11351-11358.
30. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN. 2001. Fibrocytes induce an anglogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15:2215-2224.
31. Hjelmströom P. 2001. Lymhoid neogenesis: De novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 69:331-339.
32. Hohenester E, Maurer P, Hohenadl C, Timpl R, Jansonius JN, Engel J. 1996. Structure of a novel extracellular Ca(2+)-binding module in BM-40. Nat Struct Biol 3: 67-73.
33. Iacobuzio-Donahue CA, Ryu B, Hruban RH, Kern SE. 2002a. Exploring the host desmoplastic response to pancreatic carcinoma: Gene expression of stromal and neoplastic cells at the site of primary invasion. Am J Pathol 160:91-99.
34. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE. 2002b. The desmoplastic response to infiltrating breast carcinoma: Gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 62:5351-5357.
35. Johansson U, Higginbottom K, Londei M. 2004. CD47 Ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells. Scand J Immunol 59:40-49.
36. Johnston IG, Paladine T, Gurd JW, Brown IR. 1990. Molecular cloning of SC1: A putative brain extracellular matrix glycoprotein showing partial similarity to osteonectin/BM40/SPARC. Neuron 4:165-176.
37. Jorgensen C, Noel D, Gross G. 2001. Could inflammatory arthritis be triggered by progenitor cells in the joints? Ann Rheum Dis 61:6-9.
38. Kalluri R. 2003. Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433.
39. Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS, Keating MT, Li DY. 2003. A critical role for elastin signaling in vascular morphogenesis and disease. Development 130:411-423.
40. Lau LF, Lam SC. 1999. The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 248: 44-57.
41. Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL. 1997. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med 3:171-176.
42. Margosio B, Marchetti D, Vergani V, Giavazzi R, Rusnati M, Presta M, Taraboletti G. 2003. Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2. Blood 102:4399-4406.
43. McKinnon PJ, Kapsetaki M, Margolskee RF. 1996. The exon structure of the mouse Sc1 gene is very similar to the mouse Sparc gene. Genome Res 6:1077-1083.
44. Murphy-Ullrich JE. 2001. The de-adhesive activity of matricellular proteins: Is intermediate cell adhesion an adaptive state? J Clin Invest 107:785-790.
45. Nelson PS, Plymate SR, Wang K, True LD, Ware JL, Gan L, Liu AY, Hood L. 1998. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res 58:232-236.
46. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. 2000. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60:2497-2503.
47. Oritani K, Kanakura Y, Aoyama K, Yokota T, Copeland NG, Gilbert DJ, Jenkins NA, Tomiyama Y, Matsuzawa Y, Kincade PW. 1997. Matrix glycoprotein SC1/ECM2 augments B lymphopoiesis. Blood 90:3404-3413.
48. Padera TP, Stoll BR, Tooredman JB, Capen D, Di Tomaso E, Jain RK. 2004. Cancer cells compress intratumor vessels. Nature 427:695.
49. Peale FV, Jr., Gerritsen ME. 2001. Gene profiling techniques and their application in angiogenesis and vascular development. J Pathol 195:7-19.
50. Pollard JW. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78.
51. Puolakkainen P, Bradshaw AD, Kyriakides TR, Reed M, Brekken R, Wight T, Bornstein P, Ratner B, Sage EH. 2003. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. Am J Pathol 162:627-635.
52. Rabbany SY, Heissig B, Hattori K, Rafii S. 2003. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 9:109-117.
53. Rangarajan A, Weinberg RA. 2003. Comparative biology of mouse versus human cells: Modeling human cancer in mice. Nat Rev Cancer 3:952-959.
54. Rempel SA, Ge S, Gutierrez JA. 1999. SPARC: A potential diagnostic marker of invasive meningiomas. Clin Cancer Res 5:237-241.
55. Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan C-T, Bigner DD, Counter CM, Wang XF. 2003. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 278:15951-15957.
56. Rubin H. 2001. Selected cell and selective microenvironment in neoplastic development. Cancer Res 61:799-807.
57. Ryu B, Jones J, Hollingsworth MA, Hruban RH, Kern SE. 2001. Invasion-specific genes in malignancy: Serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 61:1833-1838.
58. Sage EH. 1997. Pieces of eight: bioactive fragment of extracellular proteins as regulators of angiogenesis. Trends Cell Biol 7:182-186.
59. Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH, Bassuk JA. 2003. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem 278:37849-37857.
60. Sallusto F, Lanzavecchia A. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189:611-614.
61. Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP. 2003. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med 198:1475-1485.
62. Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M. 2003. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 22:5021-5030.
63. Schiemann BJ, Neil JR, Schiemann WP. 2003. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-β-signaling system. Mol Biol Cell 14:3977-3988.
64. Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA. 2002. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 62:6270-6277.
65. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C. 1999. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med 5:662-668.
66. Soderling JA, Reed MJ, Corsa A, Sage EH. 1997. Cloning and expression of murine SC1, a gene product homologous to SPARC. J Histochem Cytochem 45:823-835.
67. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. 2000. Genes expressed in human tumor endothelium. Science 289:1197-1202.
68. Stupack DG, Cheresh DA. 2003. Apoptotic cues from the extracellular matrix: Regulators of angiogenesis. Oncogene 22:9022-9029.
69. Sullivan MM, Sage EH. 2004. Hevin/SC1, a matricellular glycoprotein and potential tumor suppressor of the SPARC/BM-40/osteonectin family. Int J Biochem Cell Biol (in press).
70. Tanaka H, Matsui T, Agata A, Tomura M, Kubota I, McFarland KC, Kohr B, Lee A, Phillips HS, Shelton DL. 1991. Molecular cloning and expression of a novel adhesion molecule, SC1. Neuron 7:535-545.
71. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernàndez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. 2003. Hedgehog is an early and late mediator of pancreatic cancer Tumorigenesis. Nature 425:851-856.
72. Timpl R, Sasaki T, Kostka G, Chu ML. 2003. Fibulins: A versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4:479-489.
73. Vannahme C, Smyth N, Miosge N, Gosling S, Frie C, Paulsson M, Maurer P, Hartmann U. 2002. Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes. J Biol Chem 277:37977-37986.
74. Wellen KE, Hötamisligil GS. 2003. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788.
75. Yan Q, Wight T, Clark JI, Sage EH. 2002. Alterations in the Lens Capsule contribute to cataractogenesis in SPARC-null mice. J Cell Science 115:2747-2756.
76. Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS, Mok SC. 2001. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol 159:609-622.
77. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH. 2001. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 61:5168-5178.